BERGMAN CLINICS acquired by TRITON PARTNERS
Context
Triton completed an investment in Bergman Clinics alongside existing shareholders NPM Capital and the Malenstein family, who both retained minority positions in the business. The transaction followed a competitive sale process mandated to JP Morgan and Axeco Corporate Finance, which attracted interest from TowerBrook Capital Partners, Cinven, Bain Capital, and BC Partners before Triton emerged as the winning bidder. The process had originally been launched in early 2020 but was put on hold due to the COVID-19 pandemic before being revived in September 2020. Triton's investment is intended to support Bergman Clinics' continued geographic expansion, as well as investment in technological innovation, digitisation, and staff training.
BERGMAN CLINICS, which reported an EBITDA margin of LOGIN in 2018, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
Bergman Clinics is one of the leading chains of independent specialist outpatient clinics in Europe, founded nearly 30 years prior to the transaction and headquartered in Naarden, Netherlands. The group operates 140 focus clinics across five countries — the Netherlands, Sweden, Denmark, Norway, and Germany — treating more than 300,000 patients per year, supported by more than 3,000 employees and over 250 medical specialists. Bergman Clinics is a multi-specialty outpatient platform offering high-quality, plannable elective medical care across a broad range of specialties including orthopaedics, ophthalmology, gynaecology, aesthetic medicine, cardiology, gastroenterology, dermatology, and vascular medicine.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in Healthcare & Pharma
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 04/2021 | ICG / MANAGEMENT & PRIVATE INVESTORS | DOMUSVI | FRANCE | Health Providers | DomusVi completed a major capital reorganization, described as a "jumbo-LBO". This transaction allowed founder Yves Journel to increase his ownership from 30% to 49%, while ICG remains a key controlling partner. The group's management team also participated in the round, investing approximately €50 million for a 2% stake. The deal was financed through a robust structure including €1.6 billion in portable senior debt (representing 6.3x EBITDA) and a €400 million PIK (Payment-in-Kind) line provided by ICG |
| 04/2021 | AMERICAN SECURITIES | SIMONMED IMAGING | UNITED STATES | Health Providers | SimonMed Imaging has entered into a strategic partnership with American Securities, a leading US private equity firm, as part of a growth investment aimed at supporting the company's next phase of expansion. Following the transaction, American Securities has become a shareholder of SimonMed alongside the company's founder and CEO, Dr. John Simon, who retains a central role in the company's governance and strategic direction. This partnership comes at a time of significant growth in the US outpatient medical imaging market, driven by the increasing shift of diagnostic exams from hospitals to specialized centers offering lower-cost services |
| 03/2021 | EQT PARTNERS | CERBA HEALTHCARE | FRANCE | Health Providers | EQT entered into exclusive negotiations to acquire Cerba HealthCare from Partners Group. The transaction values the group at EUR4.5 billion, significantly higher than initial market estimates (EUR3bn). PSP Investments, a shareholder for four years, realized a partial cash-out but reinvested to remain a key minority partner alongside EQT and the 400 biologist-managers. The deal was financed with a massive EUR2.5 billion Senior Debt package (Term Loan B). |
| 02/2021 | SILVER LAKE / NESTLE | IVC EVIDENSIA | UNITED KINGDOM | Health Providers | Silver Lake and Nestle led a EUR3.5 billion capital investment in IVC Evidensia, significantly increasing the group's valuation. The deal allowed EQT VII to partially exit its position, while EQT IX reinvested to remain the majority shareholder. The transaction served as a private alternative to a previously considered IPO. Silver Lake's entry is designed to accelerate the group's digital transformation, while Nestle's increased stake facilitates deep collaboration between veterinary clinical care and nutritional science |
| 12/2020 | RADIOLOGY PARTNERS | MEDNAX RADIOLOGY SOLUTIONS | UNITED STATES | Health Providers | Radiology Partners has completed the acquisition of MEDNAX Radiology Solutions, bringing together two major players in the US radiology market to form a network of over 2,400 radiologists. This strategic move aims to enhance the combined entity's clinical capabilities, expand geographic coverage, and increase access to subspecialty expertise for partner healthcare institutions. The merger is also expected to facilitate the development of large-scale clinical programs and bolster investments in imaging technologies, digital solutions, and tools designed to improve the quality and efficiency of radiology services |
| 12/2020 | ANTIN INFRASTRUCTURE | HIPPOCRATES (LAF - LA FARMACIA) | ITALY | Health Providers | Antin Infrastructure Partners acquired a majority stake (approximately 80%) in Hippocrates Holding. The co-founders reinvested to retain the remaining 20% and maintained their roles as co-CEOs. The original investors (including DVR Capital and Italian family offices such as the Notarbartolo and Marzotto families) sold their shares in this transaction. The transaction was intended to provide the capital needed to accelerate the consolidation strategy in the highly fragmented Italian pharmacy market |
| 12/2020 | MEDIAN KLINIKEN | PRIORY GROUP | UNITED KINGDOM | Health Providers | MEDIAN Kliniken, a Waterland Private Equity portfolio company, agreed to acquire 100% of Priory Group from US-based Acadia Healthcare. Following closing, Waterland intends to combine Priory with MEDIAN to create a leading European rehabilitation and mental health services provider, operating 570 facilities and treating approximately 260,000 patients annually across the UK and Germany. The strategic rationale centres on geographic diversification into the UK market, cross-fertilisation of clinical expertise (particularly expanding Priory's rehabilitation services in neurology and post-acute care), and the transfer of MEDIAN's digital innovation capabilities to Priory's platform |
| 12/2020 | FRESENIUS | EUGIN GROUP | SPAIN | Health Providers | Fresenius Helios, the hospital and healthcare services division of Fresenius SE & Co. KGaA, acquired Eugin Group from NMC Health, a UAE-based listed healthcare group, through a dual acquisition structure targeting both the global ex-US operations (via Luarmia S.L.) and the US operations (via NMC Eugin US Corporation, holding 70% of Boston IVF). The remaining 30% of Boston IVF continues to be held by its senior physicians. The transaction establishes Fresenius Helios as a leading international fertility services provider and creates a new dedicated business and reporting unit — alongside Helios Germany and Helios Spain — with a mandate to pursue further buy-and-build expansion |
| 11/2020 | ARDIAN | INOVIE GROUP | FRANCE | Health Providers | Ardian led a consortium to acquire a minority stake (approx. 40% of financial rights) in Inovie. Due to French law (SEL), clinical biologists must retain the majority of voting rights and capital. The deal was designed to solve a "generational transition" problem, allowing ~130 older biologists to retire and cash out their shares while enabling younger biologists to buy in at normalized salary levels. The capital injection was earmarked for massive consolidation (Buy-and-Build) in the fragmented French lab market and for scaling specialized diagnostics |
| 11/2020 | L CATTERTON | ALLIANCE ANIMAL HEALTH | UNITED STATES | Health Providers | L Catterton acquired a majority stake in Alliance Animal Health at a valuation up to $800M. The deal reflects the high demand for recession-resistant veterinary services. Under LightBay Capital's ownership (since June 2019), Alliance grew its EBITDA fivefold to reach $39M (pro forma adjusted). The entry of L Catterton aims to accelerate the company's buy-and-build strategy in a highly fragmented market, benefiting from the increased pet ownership trend and the essential nature of veterinary care |
REFERENCES
Valuation range: EV 1b - 4b EUR
EBITDA range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of BERGMAN CLINICS by TRITON PARTNERS are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Press release: view release
Acquirer: triton partners